CCL2 and glioblastoma: Previous studies indicated strong overexpression of IL-6, IL-10, VEGF, GM-CSF, and CCL2 in human GBM specimens, and the level of overexpression strongly correlated with tumor grade, proliferation markers, and clinical aggressiveness in glioblastomas [57].